You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

TRIFLUOPERAZINE HYDROCHLORIDE Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Trifluoperazine Hydrochloride, and what generic alternatives are available?

Trifluoperazine Hydrochloride is a drug marketed by Chartwell Rx, Wockhardt, Athem, Duramed Pharms Barr, Ivax Pharms, Mylan, Sandoz, and Watson Labs. and is included in twenty NDAs.

The generic ingredient in TRIFLUOPERAZINE HYDROCHLORIDE is trifluoperazine hydrochloride. There are ten drug master file entries for this compound. Five suppliers are listed for this compound. Additional details are available on the trifluoperazine hydrochloride profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Trifluoperazine Hydrochloride

A generic version of TRIFLUOPERAZINE HYDROCHLORIDE was approved as trifluoperazine hydrochloride by SANDOZ on December 31st, 1969.

  Sign Up

AI Research Assistant
Questions you can ask:
  • What is the 5 year forecast for TRIFLUOPERAZINE HYDROCHLORIDE?
  • What are the global sales for TRIFLUOPERAZINE HYDROCHLORIDE?
  • What is Average Wholesale Price for TRIFLUOPERAZINE HYDROCHLORIDE?
Summary for TRIFLUOPERAZINE HYDROCHLORIDE
Drug patent expirations by year for TRIFLUOPERAZINE HYDROCHLORIDE
Recent Clinical Trials for TRIFLUOPERAZINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Adrianna VlachosPhase 1/Phase 2
Lindner Center of HOPEPhase 2
Alphacait, LLCPhase 2

See all TRIFLUOPERAZINE HYDROCHLORIDE clinical trials

Pharmacology for TRIFLUOPERAZINE HYDROCHLORIDE
Drug ClassPhenothiazine
Medical Subject Heading (MeSH) Categories for TRIFLUOPERAZINE HYDROCHLORIDE

US Patents and Regulatory Information for TRIFLUOPERAZINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Chartwell Rx TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride CONCENTRATE;ORAL 085787-001 Apr 15, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Mylan TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040209-004 Jul 7, 1997 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 085976-001 Jun 23, 1988 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Duramed Pharms Barr TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 088967-001 Apr 23, 1985 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Athem TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 040153-002 Oct 25, 1996 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Ivax Pharms TRIFLUOPERAZINE HYDROCHLORIDE trifluoperazine hydrochloride TABLET;ORAL 087613-001 Nov 19, 1982 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.